Cite
Framingham risk scores for determination the 10-year risk of cardiovascular disease in participants with and without the metabolic syndrome: results of the Fasa Persian cohort study.
MLA
Dehghan, Azizallah, et al. “Framingham Risk Scores for Determination the 10-Year Risk of Cardiovascular Disease in Participants with and without the Metabolic Syndrome: Results of the Fasa Persian Cohort Study.” BMC Endocrine Disorders, vol. 24, no. 1, June 2024, pp. 1–9. EBSCOhost, https://doi.org/10.1186/s12902-024-01621-5.
APA
Dehghan, A., Jahangiry, L., Khezri, R., Jafari, A., Pezeshki, B., Rezaei, F., & Aune, D. (2024). Framingham risk scores for determination the 10-year risk of cardiovascular disease in participants with and without the metabolic syndrome: results of the Fasa Persian cohort study. BMC Endocrine Disorders, 24(1), 1–9. https://doi.org/10.1186/s12902-024-01621-5
Chicago
Dehghan, Azizallah, Leila Jahangiry, Rozhan Khezri, Alireza Jafari, Babak Pezeshki, Fatemeh Rezaei, and Dagfinn Aune. 2024. “Framingham Risk Scores for Determination the 10-Year Risk of Cardiovascular Disease in Participants with and without the Metabolic Syndrome: Results of the Fasa Persian Cohort Study.” BMC Endocrine Disorders 24 (1): 1–9. doi:10.1186/s12902-024-01621-5.